OpenCell
OpenCell operates a London-based lab-as-a-service platform that rents modular BSL2+ shipping-container laboratories to biotech startups under monthly subscriptions, complemented by a deployable mobile COVID-19 testing lab and an IoT-connected Alfred operating system for equipment monitoring and consumables ordering.
- Company typePrivate
- Founded2018
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingServices
What OpenCell does
OpenCell, founded in June 2018 by Helene Steiner and Dr. Thomas Meany, operates a biotechnology laboratory infrastructure platform based in London. The company converts shipping containers into modular BSL2+ laboratories and rents them as fully serviced workspaces to biotech and life sciences startups. The core offering, branded BioHotel, comprises four tiered lab configurations (Startup, Grow, Scale, Unicorn) priced from £2,990 to £11,960+ per month across sites in White City, East London, and Hammersmith, all backed by a minimum 3-month rental commitment.
The technical stack centers on the Alfred digital lab operating system, which connects every piece of equipment via IoT sensors to a cloud dashboard for real-time monitoring of temperature, airflow, incubator status, and experimental protocol status, alongside equipment booking, consumables ordering, and waste management. An integrated online store offers validated consumables with same-day workbench delivery and a 10% member discount. The CONTAIN product line, launched in May 2020 in partnership with King's College London and Opentrons Labworks, packages this modular philosophy into deployable mobile COVID-19 diagnostics laboratories capable of processing up to 2,400 RT-qPCR tests per day from a 40-foot shipping container.
OpenCell's revenue model is primarily subscription-based monthly lab rentals, supplemented by transactional consumables sales to members. A secondary revenue stream comes from hardware sale and deployment of CONTAIN mobile testing labs to governments, airports, and healthcare organizations, exemplified by the Government of Jersey contract. Customer segments span early-stage biotech startups working in synthetic biology, gene editing, diagnostics, food tech, and biomaterials, alongside episodic engagements with healthcare providers and government agencies. As of the source period, the company reported 100+ biotech startups served and 70 shipping container labs deployed, with no institutional venture funding disclosed beyond an Innovate UK grant.
OpenCell firmographics
Firmographics- Name
- OpenCell
- Legal name
- OpenCell
- Website
- https://opencell.bio
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- OpenCell operates a London-based lab-as-a-service platform that rents modular BSL2+ shipping-container laboratories to biotech startups under monthly subscriptions, complemented by a deployable mobile COVID-19 testing lab and an IoT-connected Alfred operating system for equipment monitoring and consumables ordering.
- Ownership category
- akta.pro rank
OpenCell industry classification
Industry- Product category
- Biotech Laboratory Infrastructure (Lab-as-a-Service)
- NAICS
- Testing Laboratories and Services (541380), Medical Laboratories (621511)
- SIC
- Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Lab Middleware, Instrument Connectivity & Automation (HLACAMAI)
- akta.pro secondary industries
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Lab Furniture, Facilities & Utilities (Benches, Casework, Gas/Water Systems) (HLAGAIAM)
Keywords
Where OpenCell is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
OpenCell business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Lab Space Rental: Monthly rental of fully serviced BSL2+ lab spaces at four tier levels (Startup, Grow, Scale, Unicorn). All-inclusive rent covers water, electricity, waste management, lab coats, glassware washing, cryogenic freezer access, and IoT monitoring system. Additional fee-based access to specialist equipment including Automation lab, Diagnostic Suite, and Imaging Suite with Tissue Culture Lab.
- CONTAIN Mobile Lab Deployment: Sale and deployment of mobile COVID-19 testing laboratories built in shipping containers. Units include full BSL2+ diagnostics capability, staffing, and operational support. Revenue from government contracts, airport testing programs, and business workplace testing deployments.
- Lab Consumables Store: Online store for fully validated consumables with 10% discount for BioHotel members and same-day delivery to workbenches. Additional services include dry ice shipments and reagent delivery handling.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Startup Lab - 1-4 people, 12.8m bench space, BSL2+ |
| Subscription | Monthly | Grow Lab - 4-8 people, 20m bench space, BSL2+ |
| Subscription | Monthly | Scale Lab - 8-15 people, 32.8m bench space, BSL2+ |
| Subscription | Monthly | Unicorn Lab - 15+ people, 42.8m+ bench space, BSL2+ |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
OpenCell product offering
Product offeringCore offering
OpenCell provides fully serviced BSL2+ biotechnology laboratory space inside shipping containers on monthly subscription rental agreements to biotech and life-sciences startups in London. Its secondary offering is CONTAIN, a turnkey mobile COVID-19 diagnostics laboratory deployable globally for governments, airports, and healthcare organisations. All facilities are connected via Alfred, an in-house IoT lab management platform, and bundled with shared services such as cryogenic storage, waste management, glassware washing, sequencing, and an online consumables store.
Product overview
OpenCell provides biotechnology laboratory infrastructure through two primary offerings: the BioHotel modular lab platform and the CONTAIN mobile testing lab. The BioHotel consists of four tiers of BSL2+ labs (Startup, Grow, Scale, Unicorn) ranging from £2,990 to £11,960+ monthly, all connected via the Alfred Lab Operating System—an IoT-based platform that monitors equipment, manages protocols, books resources, and orders consumables. The CONTAIN unit is a mobile COVID-19 testing laboratory in shipping containers capable of 2,000 tests per day. Additional services include cryogenic storage, waste management, sequencing services, and an online consumables store.
Differentiator
Problem solved
Functional benefit
Brands
- CONTAIN: Mobile COVID-19 testing lab solution inside a shipping container capable of processing 2,400 tests per day
- BioHotel
- Alfred
Products and services
- BioHotel A fully serviced BSL2+ laboratory facility offering flexible monthly rental agreements for biotech and life sciences startups in London. Modular labs with IoT-connected monitoring via Alfred and bundled BioHotel services (waste, laundry, glassware, cryogenic storage, sequencing).
- CONTAIN Mobile COVID-19 Testing Lab A mobile BSL2+ COVID-19 diagnostics laboratory built inside a 40-foot shipping container. Uses Opentrons OT2 liquid-handling robots for automated RNA extraction and qPCR, capable of 2,000-2,400 RT-qPCR tests per day. Designed for rapid global deployment to governments, airports, hospitals, and businesses.
- OpenCell Shop An online store selling fully validated laboratory consumables and reagents. BioHotel members receive a 10% discount and same-day delivery to their workbench, with integration into the Alfred lab operating system.
Quantifiable outcome
- 2,400 COVID-19 tests processed per day per CONTAIN mobile lab unit
- +3 more outcomes
Companies that use OpenCell
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
OpenCell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
OpenCell partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Opentrons LabworkscoreProvided OT2 liquid handling robots for automated RNA extraction and qPCR testing in CONTAIN labs. Opentrons has deployed 250+ robots for COVID-19 testing globally. Partnership enables high-throughput processing of 2,400 tests per day.
- King's College LondoncorePartnership with King's College Hospital South London Specialist Virology Centre for COVID testing lab development. Dr. Mark Zuckerman's team provided clinical validation and accreditation support for ISO15189 standards.
- Twist BiosciencecoreProvided RNA controls essential for validating CONTAIN lab workflows and qPCR assays. Twist shipped controls rapidly during pandemic optimization phase. Emily Leproust, CEO, stated support for the collaboration as an example of how research should work.
- Oxford Nanopore TechnologiescoreProvided MinION MK1C portable sequencers for COVID-19 viral variant monitoring. Used for rapid genome sequencing of SARS-CoV-2 to identify mutations and variants of concern.
- Government of JerseycoreContracted to provide on-island COVID-19 testing at airport and ports. CONTAIN lab processes over 1,000 passengers daily with <12 hour turnaround. First international deployment of OpenCell technology.
- Cardiff UniversityminorAcademic collaborator on CONTAIN project contributing to open-source COVID testing lab development.
- Imperial College LondoncoreFounding academic partner and source of founding team (Helene Steiner, Thomas Meany). Located in White City Innovation District near Imperial College campus. Provides access to talent and research collaboration.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
OpenCell competitors and assessment
Company assessmentDirect peers
- BioLabs: Operator of shared, fully serviced coworking lab facilities for life science startups across multiple U.S. and European sites — directly comparable business model to OpenCell's BioHotel, with similar tiered lab offerings and resident-company community approach.
- LabCentral: Cambridge, MA-based nonprofit coworking laboratory for high-potential biotech startups, offering fully equipped BSL2 lab benches on flexible rental terms — directly comparable to OpenCell's BioHotel startup-tier offering and similar mission of lowering barriers to biotech entry.
- The Biosphere: Manchester-based flexible BSL2 laboratory coworking space for biotech and life sciences startups, offering serviced lab benches and equipment access — directly comparable to OpenCell's BioHotel and serving a similar UK early-stage biotech customer base.
Broad incumbents
- Eurofins Scientific: Global testing services group operating a large network of BSL2/3 laboratories across life sciences, food, and clinical diagnostics — broad incumbent comparable to OpenCell's CONTAIN COVID testing operations and its general BSL2+ lab service capability.
- Charles River Laboratories: Major global CRO providing preclinical, laboratory, and manufacturing services to biotech and pharma — broad incumbent serving a comparable biotech customer base, although operating at a much larger scale and with a regulatory/mammalian-cell focus OpenCell does not pursue.
- Lonza: Global CDMO and bioprocessing services provider offering lab, manufacturing, and testing infrastructure to biotech customers — broad incumbent that serves many of the same startup biotech customers but at significantly larger scale and with GMP capabilities OpenCell does not offer.
- Concept Life Sciences: UK-based CRO/CDMO providing integrated drug discovery, development, and analytical services — broader and more established life sciences services incumbent whose service portfolio overlaps OpenCell's BSL2 lab and sequencing service offerings.
Regional players
- BioCity: UK-based life sciences business incubator and lab workspace operator with sites in Nottingham, Glasgow, and elsewhere — comparable coworking lab model for biotech startups but with a broader UK footprint and longer operating history.
Others
- LabWare: Provider of Laboratory Information Management Systems (LIMS) and instrument integration software — adjacent technology vendor whose platform addresses the same laboratory middleware and instrument connectivity problem that OpenCell's Alfred OS targets.
- Opentrons Labworks: Manufacturer of affordable lab automation robots (OT-2) and partner in OpenCell's CONTAIN system — adjacent ecosystem participant and technology supplier rather than a direct competitor, but its flexible lab automation stack increasingly enables competing coworking-lab models.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
OpenCell social profiles
Digital presenceOpenCell compliance and trust
Trust signalCompliance2 records
OpenCell financial estimates
Financial estimateRevenue estimate
Valuation estimate
OpenCell leadership team
Management profileNumber of profiles
Profiles3 records
OpenCell funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OpenCell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OpenCell
What does OpenCell do?
OpenCell provides fully serviced BSL2+ biotechnology laboratory space inside shipping containers on monthly subscription rental agreements to biotech and life-sciences startups in London. Its secondary offering is CONTAIN, a turnkey mobile COVID-19 diagnostics laboratory deployable globally for governments, airports, and healthcare organisations. All facilities are connected via Alfred, an in-house IoT lab management platform, and bundled with shared services such as cryogenic storage, waste management, glassware washing, sequencing, and an online consumables store.
Is OpenCell a public or private company?
OpenCell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was OpenCell founded?
OpenCell was founded in 2018. It employs 11 to 50 people.
Where is OpenCell based?
OpenCell is headquartered in London, United Kingdom, in the Europe region.
How does OpenCell make money?
Three revenue lines are on record. Lab Space Rental is the primary driver. The others are CONTAIN Mobile Lab Deployment and lab Consumables Store.
Who are OpenCell's main competitors?
Direct peers on record are BioLabs, LabCentral and The Biosphere. Broad incumbents are Eurofins Scientific, Charles River Laboratories, Lonza and Concept Life Sciences. BioCity is listed as a regional player. Others are LabWare and Opentrons Labworks.
Does OpenCell have an API?
No public API is recorded for OpenCell.
What industry is OpenCell in?
OpenCell's product category is Biotech Laboratory Infrastructure (Lab-as-a-Service). Its primary akta.pro industry code is HLACAMAI, Lab Middleware, Instrument Connectivity & Automation, with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 541380 and its SIC code is 8734.